01 September 1997
Molecular genotyping of the arylamine N-acetyltransferase polymorphism in children
Elżbieta Zielińska, Wojciech Niewiarowski, Jerzy Bodalski, Grzegorz Rębowski, Iwona MatusiakMed Sci Monit 1997; 3(5): CR661-668 :: ID: 501566
Abstract
Mutations of the N-acetyltransferase-encoding gene (NAT2) underlie inter-individual and inter-ethnic differences in pharmacokinetics of arylamines and hydrazines and belong to factors that account for the increased risk of cancer and idiosyncratic reactions to drugs.In the present study we determined frequencies of the NAT2 genotype and the NAT2 gene mutations in the population of children from central Poland in order to develop a prophylactic system against the adverse drug effects and to highlight the genetic basis of the elevated risk of diseases caused by environmental factors. To this end, genomic DNA was isolated from one to two millilitres of blood collected from 197 Polish children hospitalised with various infections. Polymerase chain reaction (PCR) was then carried out followed by the restriction mapping with the KpnI, TaqI, DdeI, and BamHI endonucleases in order to identify the six alleles at the NAT2 gene locus: wild-type 'fast acetylator' allele (wt), and five mutant 'slow acetylator' alleles designated 5A (481C→T), 5B (481C→T;803A→G), 5C (803A→G), 6A (590G→A), and 7B (857G→A). The following allele frequencies were detected: wt - 22.3%, 5A - 19.0%, 5B - 18.8%, 5C - 8.6%, 6A - 22.3%, and 7B - 9.4%. The most frequent mutations were 803G and 481T, immediately followed by mutations 590A and 857A. The wild-type allele was detected in 75 (38%) children and the slow acetylation genotype was found in 122 (62%) children. These frequencies compare well with the distribution of NAT2 in the children populations from other parts of Europe. Altogether, the present results indicate that determination of the NAT2 genotype is a useful method for detection of the acetylation defect and for estimating the risk of idiosyncratic disorders and hypersensitivity to drugs in children.
Keywords: N-Acetyltransferase, genotype NAT2, Pharmacogenetics, Polymerase Chain Reaction
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952